Literature DB >> 25251948

Effect of increasing respiratory rate on airway resistance and reactance in COPD patients.

Misa Nakagawa1, Noboru Hattori, Yoshinori Haruta, Aya Sugiyama, Hiroshi Iwamoto, Nobuhisa Ishikawa, Kazunori Fujitaka, Hiroshi Murai, Junko Tanaka, Nobuoki Kohno.   

Abstract

BACKGROUND AND
OBJECTIVE: Airway resistance and reactance measured by forced oscillometry have been used to measure the severity of airway obstruction in chronic obstructive pulmonary disease (COPD) patients. The aims of this study were to assess the effects of tachypnoea on airway resistance and reactance and to correlate these with the severity of dyspnoea. We also evaluated the effects of short-acting β2-agonist (SABA) on these measurements.
METHODS: Airway resistance and reactance were measured with an impulse oscillation system (IOS) in 20 COPD and 10 control participants during resting respiration and metronome-paced breathing at 20, 30 and 40 tidal breaths/min. The same measurements were made for COPD patients after SABA inhalation. Dyspnoea was evaluated using the modified Medical Research Council (MRC) scale.
RESULTS: In patients with COPD, higher respiratory rates increased expiratory and inspiratory resistance at 5 Hz (R5), the difference in respiratory resistance at 5 Hz and 20 Hz (R5-R20), resonant frequency and decreased expiratory reactance. The decreases in expiratory reactance from 20 to 40 tidal breaths/min were significantly correlated with MRC scores. SABA inhalation significantly reduced the effect of increased respiratory rate on the reactance measurements.
CONCLUSIONS: Characteristic changes in IOS measurements, particularly expiratory reactance, induced by increased respiratory rates, were correlated with severity of dyspnoea in COPD patients during their daily lives. IOS and paced breathing may be useful for assessing breathlessness in COPD.
© 2014 Asian Pacific Society of Respirology.

Entities:  

Keywords:  chronic obstructive pulmonary disease; dyspnoea; forced oscillometry; metronome-paced tachypnoea; reactance

Mesh:

Year:  2014        PMID: 25251948     DOI: 10.1111/resp.12387

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  5 in total

1.  Quercetin Improves Pulmonary Function and Prevents Emphysema Caused by Exposure to Cigarette Smoke in Male Mice.

Authors:  Natália Pereira da Silva Araújo; Natália Alves de Matos; Michel Oliveira; Ana Beatriz Farias de Souza; Thalles de Freitas Castro; Pedro Alves Machado-Júnior; Débora Maria Soares de Souza; André Talvani; Sílvia Dantas Cangussú; Rodrigo Cunha Alvim de Menezes; Frank Silva Bezerra
Journal:  Antioxidants (Basel)       Date:  2022-01-18

2.  Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls.

Authors:  Nobuhisa Ishikawa; Noboru Hattori; Nobuoki Kohno; Akihiro Kobayashi; Tomoyuki Hayamizu; Malcolm Johnson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-01-23

3.  Significances of spirometry and impulse oscillometry for detecting small airway disorders assessed with endobronchial optical coherence tomography in COPD.

Authors:  Zhu-Quan Su; Wei-Jie Guan; Shi-Yue Li; Ming Ding; Yu Chen; Mei Jiang; Xiao-Bo Chen; Chang-Hao Zhong; Chun-Li Tang; Nan-Shan Zhong
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-01

4.  Development and validation of a simple tool composed of items on dyspnea, respiration rates, and C-reactive protein for pneumonia prediction among acute febrile respiratory illness patients in primary care settings.

Authors:  Fengming Ding; Lei Han; Dongning Yin; Yan Zhou; Yong Ji; Pengyu Zhang; Wensheng Wu; Jijing Chen; Zufang Wang; Xinxin Fan; Guoqing Zhang; Min Zhang
Journal:  BMC Med       Date:  2022-10-18       Impact factor: 11.150

5.  Induction of dynamic hyperinflation by expiratory resistance breathing in healthy subjects - an efficacy and safety study.

Authors:  Matthias Helmut Urban; Anna Katharina Mayr; Ingrid Schmidt; Eduard Margulies; Erwin Grasmuk-Siegl; Otto Chris Burghuber; Georg-Christian Funk
Journal:  Exp Physiol       Date:  2020-11-23       Impact factor: 2.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.